Reversal of multidrug resistance phenotype in human breast cancer cells using doxorubicin-liposome–microbubble complexes assisted by ultrasound

Perez, 2009, Impact, mechanisms, and novel chemotherapy strategies for overcoming resistance to anthracyclines and taxanes in metastatic breast cancer, Breast Cancer Res. Treat., 114, 195, 10.1007/s10549-008-0005-6 Gottesman, 1993, How cancer-cells evade chemotherapy — 16th Richard-and-Hinda-Rosenthal-Foundation Award Lecture, Cancer Res., 53, 747 Szakacs, 2006, Targeting multidrug resistance in cancer, Nat. Rev. Drug Discov., 5, 219, 10.1038/nrd1984 Lee, 2010, Reversing agents for ATP-binding cassette drug transporters, Methods Mol. Biol., 596, 325, 10.1007/978-1-60761-416-6_14 Tsuruo, 1981, Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil, Cancer Res., 41, 1967 Twentyman, 1987, Cyclosporine-a and its analogs as modifiers of adriamycin and vincristine resistance in a multidrug resistant human-lung cancer cell-line, Br. J. Cancer, 56, 55, 10.1038/bjc.1987.153 Dantzig, 2001, Reversal of multidrug resistance by the P-glycoprotein modulator, LY335979, from the bench to the clinic, Curr. Med. Chem., 8, 39, 10.2174/0929867013373903 Pan, 2013, Overcoming multidrug resistance of cancer cells by direct intranuclear drug delivery using TAT-conjugated mesoporous silica nanoparticles, Biomaterials, 34, 2719, 10.1016/j.biomaterials.2012.12.040 Yan, 2010, The effect of poloxamer 188 on nanoparticle morphology, size, cancer cell uptake, and cytotoxicity, Nanomedicine, 6, 170, 10.1016/j.nano.2009.05.004 Kheirolomoom, 2007, Acoustically-active microbubbles conjugated to liposomes: characterization of a proposed drug delivery vehicle, J. Control. Release, 118, 275, 10.1016/j.jconrel.2006.12.015 Mehier-Humbert, 2005, Plasma membrane poration induced by ultrasound exposure: implication for drug delivery, J. Control. Release, 104, 213, 10.1016/j.jconrel.2005.01.007 Krasovitski, 2011, Intramembrane cavitation as a unifying mechanism for ultrasound-induced bioeffects, Proc. Natl. Acad. Sci. U. S. A., 108, 3258, 10.1073/pnas.1015771108 Lentacker, 2010, Design and evaluation of doxorubicin-containing microbubbles for ultrasound-triggered doxorubicin delivery: cytotoxicity and mechanisms involved, Mol. Ther., 18, 101, 10.1038/mt.2009.160 Yan, 2013, Paclitaxel-liposome–microbubble complexes as ultrasound-triggered therapeutic drug delivery carriers, J. Control. Release, 166, 246, 10.1016/j.jconrel.2012.12.025 Wang, 1999, Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reader, Free Radic. Biol. Med., 27, 612, 10.1016/S0891-5849(99)00107-0 Rogan, 1984, Reversal of adriamycin resistance by verapamil in human ovarian cancer, Science, 224, 994, 10.1126/science.6372095 Rogakou, 2000, Initiation of DNA fragmentation during apoptosis induces phosphorylation of H2AX histone at serine 139, J. Biol. Chem., 275, 9390, 10.1074/jbc.275.13.9390 Miller, 1991, P-glycoprotein expression in malignant lymphoma and reversal of clinical drug resistance with chemotherapy plus high-dose verapamil, J. Clin. Oncol., 9, 17, 10.1200/JCO.1991.9.1.17 Wu, 2008, Ultrasound, cavitation bubbles and their interaction with cells, Adv. Drug Deliv. Rev., 60, 1103, 10.1016/j.addr.2008.03.009 El Ouahabi, 1997, The role of endosome destabilizing activity in the gene transfer process mediated by cationic lipids, FEBS Lett., 414, 187, 10.1016/S0014-5793(97)00973-3 Seynhaeve, 2013, Intact Doxil is taken up intracellularly and released doxorubicin sequesters in the lysosome: evaluated by in vitro/in vivo live cell imaging, J. Control. Release, 172, 330, 10.1016/j.jconrel.2013.08.034 Meijering, 2009, Ultrasound and microbubble-targeted delivery of macromolecules is regulated by induction of endocytosis and pore formation, Circ. Res., 104, 679-U226, 10.1161/CIRCRESAHA.108.183806 Gewirtz, 1999, A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin, Biochem. Pharmacol., 57, 727, 10.1016/S0006-2952(98)00307-4 Banerjee, 2004, Anisamide-targeted stealth liposomes: a potent carrier for targeting doxorubicin to human prostate cancer cells, Int. J. Cancer, 112, 693, 10.1002/ijc.20452 Juffermans, 2006, Transient permeabilization of cell membranes by ultrasound-exposed microbubbles is related to formation of hydrogen peroxide, Am. J. Physiol. Heart Circ. Physiol., 291, H1595, 10.1152/ajpheart.01120.2005 Basta, 2003, In vitro modulation of intracellular oxidative stress of endothelial cells by diagnostic cardiac ultrasound, Cardiovasc. Res., 58, 156, 10.1016/S0008-6363(02)00665-X Mizutani, 2005, Mechanism of apoptosis induced by doxorubicin through the generation of hydrogen peroxide, Life Sci., 76, 1439, 10.1016/j.lfs.2004.05.040 Ubezio, 1994, Flow cytometric detection of hydrogen peroxide production induced by doxorubicin in cancer cells, Free Radic. Biol. Med., 16, 509, 10.1016/0891-5849(94)90129-5 Milowska, 2007, Reactive oxygen species and DNA damage after ultrasound exposure, Biomol. Eng., 24, 263, 10.1016/j.bioeng.2007.02.001 Mizutani, 2003, Distinct mechanisms of site-specific oxidative DNA damage by doxorubicin in the presence of copper(II) and NADPH-cytochrome P450 reductase, Cancer Sci., 94, 686, 10.1111/j.1349-7006.2003.tb01503.x Germann, 1996, P-glycoprotein—a mediator of multidrug resistance in tumour cells, Eur. J. Cancer, 32A, 927, 10.1016/0959-8049(96)00057-3 Donmez, 2011, Effect of MDR modulators verapamil and promethazine on gene expression levels of MDR1 and MRP1 in doxorubicin-resistant MCF-7 cells, Cancer Chemother. Pharmacol., 67, 823, 10.1007/s00280-010-1385-y Gruber, 2010, Synergistic action of doxorubicin and sulindac in human cervix carcinoma cells — studies on possible mechanisms, Med. Sci. Monit., 16, BR45 Brayman, 1999, Transient poration and cell surface receptor removal from human lymphocytes in vitro by 1MHz ultrasound, Ultrasound Med. Biol., 25, 999, 10.1016/S0301-5629(99)00039-3 Bohmer, 2010, Focused ultrasound and microbubbles for enhanced extravasation, J. Control. Release, 148, 18, 10.1016/j.jconrel.2010.06.012